Resistance to mammalian target of rapamycin inhibitor therapy in perivascular epithelioid cell tumors
- PMID: 20567010
- DOI: 10.1200/JCO.2010.29.4678
Resistance to mammalian target of rapamycin inhibitor therapy in perivascular epithelioid cell tumors
Comment on
-
Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.J Clin Oncol. 2010 Feb 10;28(5):835-40. doi: 10.1200/JCO.2009.25.2981. Epub 2010 Jan 4. J Clin Oncol. 2010. PMID: 20048174 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous